Keyword: Eli Lilly

News

Lilly Boosts Dermatology with Dermira Buy

15.01.2020 - Eli Lilly has agreed to pay around $1.1 billion cash to buy Dermira, a biopharma focused on developing therapies for chronic skin conditions. The acquisition will add lebrikizumab...

News

US to Allow Drug Reimports from Canada

20.12.2019 - The US Department of Health and Human Services (HHS) is proposing that state governments allow drugmakers to reimport their products from Canada, where they are generally cheaper...

News

Lilly in $400 Million Expansion at Indianapolis

21.11.2019 - Eli Lilly is investing $400 million at its Lilly Technology Center campus in Indianapolis, Indiana, USA, to expand capacity for its growing portfolio of diabetes medicines and...

News

Bayer Animal Health and VLPbio to Collaborate

29.10.2019 - Germany’s Bayer Animal Health and Vallidolid, Spain-based VLPbio have signed a global collaboration agreement to discover and develop a new generation of immunotherapeutic...

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...

News

Lilly Wins Alimta Appeal

23.08.2019 - US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories. The US...

News

Bayer and Elanco Animal Health Link-up?

18.07.2019 - Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare...